Report Detail

Other Global Genital Herpes Research and Development Pipeline Market Size, Status and Forecast 2021-2027

  • RnM4312870
  • |
  • 20 April, 2021
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Genital Herpes Research and Development Pipeline Market Size Growth Rate by Type (2021-2027)
    • 1.2.2 Acyclovir
    • 1.2.3 Aspidasept
    • 1.2.4 G-103
    • 1.2.5 GEN-003
    • 1.2.6 GV-2207
    • 1.2.7 HerpeCide-I
    • 1.2.8 HSV-529
    • 1.2.9 Pritelivir
    • 1.2.10 SB-105A10
  • 1.3 Market by Application
    • 1.3.1 Global Genital Herpes Research and Development Pipeline Market Share by Application (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Genital Herpes Research and Development Pipeline Market Size
  • 2.2 Genital Herpes Research and Development Pipeline Market Size by Regions
    • 2.2.1 Genital Herpes Research and Development Pipeline Growth Rate by Regions (2021-2027)
    • 2.2.2 Genital Herpes Research and Development Pipeline Market Share by Regions (2021-2027)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Use Cases

3 Key Players

  • 3.1 Genital Herpes Research and Development Pipeline Revenue by Players (2020-2021)
  • 3.2 Genital Herpes Research and Development Pipeline Key Players Headquaters and Area Served
  • 3.3 Key Players Genital Herpes Research and Development Pipeline Product/Solution/Service
  • 3.4 Date of Enter into Genital Herpes Research and Development Pipeline Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application

  • 4.1 Global Genital Herpes Research and Development Pipeline Market Size by Type (2021-2027)
  • 4.2 Global Genital Herpes Research and Development Pipeline Market Size by Application (2021-2027)

5 North America

  • 5.1 North America Genital Herpes Research and Development Pipeline Market Forecast (2021-2027)
  • 5.2 Genital Herpes Research and Development Pipeline Key Players in North America
  • 5.3 North America Genital Herpes Research and Development Pipeline Market Size by Type
  • 5.4 North America Genital Herpes Research and Development Pipeline Market Size by Application
    • 6.4.4 Canada

6 Europe

  • 6.1 Europe Genital Herpes Research and Development Pipeline Market Forecast (2021-2027)
  • 6.2 Genital Herpes Research and Development Pipeline Key Players in Europe
  • 6.3 Europe Genital Herpes Research and Development Pipeline Market Size by Type
  • 6.4 Europe Genital Herpes Research and Development Pipeline Market Size by Application

7 Japan

  • 7.1 Japan Genital Herpes Research and Development Pipeline Market Forecast (2021-2027)
  • 7.2 Genital Herpes Research and Development Pipeline Key Players in Europe
  • 7.3 Japan Genital Herpes Research and Development Pipeline Market Size by Type
  • 7.4 Japan Genital Herpes Research and Development Pipeline Market Size by Application

8 Rest of World

  • 8.1 China
    • 8.1.1 China Genital Herpes Research and Development Pipeline Market Analysis
    • 8.1.2 Key Players in China
  • 8.2 Southeast Asia
    • 8.2.1 Southeast Asia Genital Herpes Research and Development Pipeline Market Analysis
    • 8.2.2 Key Players in Southeast Asia
  • 8.3 India
    • 8.3.1 India Genital Herpes Research and Development Pipeline Market Analysis
    • 8.3.2 Key Players in India

9 International Player Profiles

  • 9.1 AiCuris GmbH & Co. KG
    • 9.1.1 AiCuris GmbH & Co. KG Company Details
    • 9.1.2 AiCuris GmbH & Co. KG Description and Business Overview
    • 9.1.3 AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Introduction
    • 9.1.4 AiCuris GmbH & Co. KG Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.1.5 AiCuris GmbH & Co. KG Recent Development
  • 9.2 AlphaVax, Inc.
    • 9.2.1 AlphaVax, Inc. Company Details
    • 9.2.2 AlphaVax, Inc. Description and Business Overview
    • 9.2.3 AlphaVax, Inc. Genital Herpes Research and Development Pipeline Introduction
    • 9.2.4 AlphaVax, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.2.5 AlphaVax, Inc. Recent Development
  • 9.3 Foamix Pharmaceuticals Ltd.
    • 9.3.1 Foamix Pharmaceuticals Ltd. Company Details
    • 9.3.2 Foamix Pharmaceuticals Ltd. Description and Business Overview
    • 9.3.3 Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Introduction
    • 9.3.4 Foamix Pharmaceuticals Ltd. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.3.5 Foamix Pharmaceuticals Ltd. Recent Development
  • 9.4 Genocea Biosciences, Inc.
    • 9.4.1 Genocea Biosciences, Inc. Company Details
    • 9.4.2 Genocea Biosciences, Inc. Description and Business Overview
    • 9.4.3 Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Introduction
    • 9.4.4 Genocea Biosciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.4.5 Genocea Biosciences, Inc. Recent Development
  • 9.5 GenVec, Inc.
    • 9.5.1 GenVec, Inc. Company Details
    • 9.5.2 GenVec, Inc. Description and Business Overview
    • 9.5.3 GenVec, Inc. Genital Herpes Research and Development Pipeline Introduction
    • 9.5.4 GenVec, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.5.5 GenVec, Inc. Recent Development
  • 9.6 Immune Design Corp.
    • 9.6.1 Immune Design Corp. Company Details
    • 9.6.2 Immune Design Corp. Description and Business Overview
    • 9.6.3 Immune Design Corp. Genital Herpes Research and Development Pipeline Introduction
    • 9.6.4 Immune Design Corp. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.6.5 Immune Design Corp. Recent Development
  • 9.7 Immunovaccine, Inc.
    • 9.7.1 Immunovaccine, Inc. Company Details
    • 9.7.2 Immunovaccine, Inc. Description and Business Overview
    • 9.7.3 Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Introduction
    • 9.7.4 Immunovaccine, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.7.5 Immunovaccine, Inc. Recent Development
  • 9.8 Mymetics Corporation
    • 9.8.1 Mymetics Corporation Company Details
    • 9.8.2 Mymetics Corporation Description and Business Overview
    • 9.8.3 Mymetics Corporation Genital Herpes Research and Development Pipeline Introduction
    • 9.8.4 Mymetics Corporation Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.8.5 Mymetics Corporation Recent Development
  • 9.9 NanoBio Corporation
    • 9.9.1 NanoBio Corporation Company Details
    • 9.9.2 NanoBio Corporation Description and Business Overview
    • 9.9.3 NanoBio Corporation Genital Herpes Research and Development Pipeline Introduction
    • 9.9.4 NanoBio Corporation Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.9.5 NanoBio Corporation Recent Development
  • 9.10 NanoViricides, Inc.
    • 9.10.1 NanoViricides, Inc. Company Details
    • 9.10.2 NanoViricides, Inc. Description and Business Overview
    • 9.10.3 NanoViricides, Inc. Genital Herpes Research and Development Pipeline Introduction
    • 9.10.4 NanoViricides, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.10.5 NanoViricides, Inc. Recent Development
  • 9.11 PaxVax
    • 9.11.1 PaxVax Company Details
    • 9.11.2 PaxVax Description and Business Overview
    • 9.11.3 PaxVax Genital Herpes Research and Development Pipeline Introduction
    • 9.11.4 PaxVax Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.11.5 PaxVax Recent Development
  • 9.12 Profectus BioSciences, Inc.
    • 9.12.1 Profectus BioSciences, Inc. Company Details
    • 9.12.2 Profectus BioSciences, Inc. Description and Business Overview
    • 9.12.3 Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline Introduction
    • 9.12.4 Profectus BioSciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.12.5 Profectus BioSciences, Inc. Recent Development
  • 9.13 Sanofi Pasteur SA
    • 9.13.1 Sanofi Pasteur SA Company Details
    • 9.13.2 Sanofi Pasteur SA Description and Business Overview
    • 9.13.3 Sanofi Pasteur SA Genital Herpes Research and Development Pipeline Introduction
    • 9.13.4 Sanofi Pasteur SA Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.13.5 Sanofi Pasteur SA Recent Development
  • 9.14 Spider Biotech
    • 9.14.1 Spider Biotech Company Details
    • 9.14.2 Spider Biotech Description and Business Overview
    • 9.14.3 Spider Biotech Genital Herpes Research and Development Pipeline Introduction
    • 9.14.4 Spider Biotech Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.14.5 Spider Biotech Recent Development
  • 9.15 Starpharma Holdings Limited
    • 9.15.1 Starpharma Holdings Limited Company Details
    • 9.15.2 Starpharma Holdings Limited Description and Business Overview
    • 9.15.3 Starpharma Holdings Limited Genital Herpes Research and Development Pipeline Introduction
    • 9.15.4 Starpharma Holdings Limited Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.15.5 Starpharma Holdings Limited Recent Development
  • 9.16 Vaccibody AS
    • 9.16.1 Company Details
    • 9.16.2 Vaccibody AS Description and Business Overview
    • 9.16.3 Vaccibody AS Genital Herpes Research and Development Pipeline Introduction
    • 9.16.4 Vaccibody AS Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.16.5 Vaccibody AS Recent Development
  • 9.17 Vaxart, Inc.
    • 9.17.1 Vaxart, Inc. Company Details
    • 9.17.2 Vaxart, Inc. Description and Business Overview
    • 9.17.3 Vaxart, Inc. Genital Herpes Research and Development Pipeline Introduction
    • 9.17.4 Vaxart, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.17.5 Vaxart, Inc. Recent Development
  • 9.18 Vical Incorporated.
    • 9.18.1 Vical Incorporated. Company Details
    • 9.18.2 Vical Incorporated. Description and Business Overview
    • 9.18.3 Vical Incorporated. Genital Herpes Research and Development Pipeline Introduction
    • 9.18.4 Vical Incorporated. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
    • 9.18.5 Vical Incorporated. Recent Development

10 Market Dynamics

  • 10.1 Industry Trends
  • 10.2 Market Drives
  • 10.3 Market Challenges
  • 10.4 Market Restraints

11 Key Findings in This Report

    12 Appendix

    • 12.1 Research Methodology
      • 12.1.1 Methodology/Research Approach
      • 12.1.2 Data Source
    • 12.2 Disclaimer

    Global Genital Herpes Research and Development Pipeline Scope and Market Size
    Genital Herpes Research and Development Pipeline market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genital Herpes Research and Development Pipeline market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Acyclovir
    Aspidasept
    G-103
    GEN-003
    GV-2207
    HerpeCide-I
    HSV-529
    Pritelivir
    SB-105A10

    Segment by Application
    Hospital
    Clinic

    By Region
    North America
    Europe
    Japan
    China
    Southeast Asia
    India

    By Company
    AiCuris GmbH & Co. KG
    AlphaVax, Inc.
    Foamix Pharmaceuticals Ltd.
    Genocea Biosciences, Inc.
    GenVec, Inc.
    Immune Design Corp.
    Immunovaccine, Inc.
    Mymetics Corporation
    NanoBio Corporation
    NanoViricides, Inc.
    PaxVax
    Profectus BioSciences, Inc.
    Sanofi Pasteur SA
    Spider Biotech
    Starpharma Holdings Limited
    Vaccibody AS
    Vaxart, Inc.
    Vical Incorporated.


    Summary:
    Get latest Market Research Reports on Genital Herpes Research and Development Pipeline. Industry analysis & Market Report on Genital Herpes Research and Development Pipeline is a syndicated market report, published as Global Genital Herpes Research and Development Pipeline Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Genital Herpes Research and Development Pipeline market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,769.00
    4,153.50
    5,538.00
    3,213.60
    4,820.40
    6,427.20
    426,621.00
    639,931.50
    853,242.00
    286,026.00
    429,039.00
    572,052.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report